Labshake search
Citations for R&D Systems :
651 - 700 of 3688 citations for En 1948 4 Marker Pcb Extraction Spike 13C12 99% 100 Ng Ml In Nonane since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with 30 ng/ml VEGF (R&D Systems), 20 ng/mL bFGF (Milteny Biotech ...
-
bioRxiv - Bioengineering 2020Quote: ... supplemented with 20 ng/mL bFGF (R&D Systems), 10 μM all-trans retinoic acid (Sigma ...
-
bioRxiv - Cancer Biology 2020Quote: ... 5 ng/ml GRO-α (R&D Systems, Germany), 20 ng/ml hyper interleukin-6 (kindly provided by S ...
-
bioRxiv - Bioengineering 2021Quote: ... 50 ng/mL SCF (R&D Systems 255-SC), 20ng/mL IL-3 (R&D Systems 203-IL) ...
-
bioRxiv - Neuroscience 2021Quote: ... 10 ng/mL recombinant GDNF (R&D Systems, USA), 10 ng/mL recombinant human IGF-1 (R&D Systems ...
-
bioRxiv - Neuroscience 2021Quote: ... 10 ng/mL recombinant BDNF (R&D Systems, USA), 10 ng/mL recombinant GDNF (R&D Systems ...
-
bioRxiv - Microbiology 2021Quote: ... TNFα (20 ng / mL, 210-TA, R&D Systems) was applied apically to HAE cultures ...
-
bioRxiv - Cell Biology 2021Quote: ... with 20 ng/ml rmIL-3 (R&D Systems), 50 ng/ml Flt3-Ligand (R&D Systems ...
-
bioRxiv - Developmental Biology 2022Quote: ... 200ng/mL NOGGIN (R&D Systems, Cat#6057-NG), 2uM CHIR99021 (APExBIO ...
-
bioRxiv - Immunology 2022Quote: ... and IL-18 (50 ng/ml; R&D Systems) were added to the cytokine stimulation condition ...
-
bioRxiv - Immunology 2022Quote: ... and 12 ng/ml IL-10 (R&D Systems) in order to promote the differentiation into plasmablasts (“2nd step differentiation cocktail”)8 ...
-
bioRxiv - Immunology 2022Quote: ... and 12 ng/ml IL-10 (R&D Systems).
-
bioRxiv - Molecular Biology 2020Quote: ... and TNF-α (10 ng/ml, R&D Systems) in the presence of IncuCyte Caspase-3/7 green reagent (IncuCyte ...
-
bioRxiv - Molecular Biology 2020Quote: ... and IFN-γ (50 ng/ml, R&D Systems) and TNF-α (10 ng/ml ...
-
bioRxiv - Microbiology 2020Quote: ... and 2.5 ng/ml TNF-α (R&D systems) for 11 days ...
-
Targeted attenuation of elevated histone marks at SNCA alleviates α-synuclein in Parkinson’s diseasebioRxiv - Neuroscience 2020Quote: ... 1 ng/ml TGFb3(R&D Systems, 243B3002/CF), and 0.1 mM dibutyryl cAMP (Sigma ...
-
bioRxiv - Cell Biology 2021Quote: ... and 10 ng/ml recombinant NRG1 (R&D Systems). Where indicated ...
-
bioRxiv - Bioengineering 2020Quote: ... supplemented with BDNF (10 ng/mL, R&D Systems), GDNF (10 ng/mL ...
-
bioRxiv - Developmental Biology 2022Quote: ... and 50 ng/ml activin A (R&D Systems) for 3 d ...
-
bioRxiv - Developmental Biology 2022Quote: ... 50 ng/ml EGF (R&D Systems, 236-EG), 10 ng/ml LIF (Millipore ...
-
bioRxiv - Developmental Biology 2022Quote: ... supplemented with 20 ng/mL BMP4 (R&D Systems), 20 ng/mL ACTIVIN A (Miltenyi Biotec ...
-
bioRxiv - Pathology 2022Quote: ... or 20 ng/mL IL-1β (R&D Systems) in the presence or absence of a selective IKKα and IKKβ inhibitor ...
-
bioRxiv - Cancer Biology 2019Quote: ... 20 ng/mL rhEGF (R&D Systems #236-EG), 10 μg/mL insulin (Sigma #I9278) ...
-
bioRxiv - Immunology 2019Quote: ... and TNF-α (2.5 ng/ml, R&D systems) for 7 days ...
-
bioRxiv - Cancer Biology 2019Quote: ... 10 ng/ml bFGF (R&D Systems; Minneapolis, MN), and 0.4% BSA using 6-well ultra-low attachment plates (Corning Life Sciences ...
-
bioRxiv - Cell Biology 2019Quote: ... recombinant human VEGF165 (5 ng/ml, R&D Systems), recombinant human FGF basic146 aa (10 ng/ml ...
-
bioRxiv - Immunology 2019Quote: ... (5) IL-1β (2 ng/ml, R&D Systems), (6 ...
-
bioRxiv - Genetics 2021Quote: ... 3 ng/ml mouse IL-3 (R&D Systems) and 20% L-cell conditioned medium ...
-
bioRxiv - Neuroscience 2021Quote: ... and Activin A (15 ng/ml; R&D Systems). Every seven days ...
-
bioRxiv - Cell Biology 2020Quote: ... and 30 ng/ml murine RANKL (R&D Systems). To study the impact of adiporon on osteoclast differentiation ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 2.5 ng/ml TGF-β (R&D system) for 3 days ...
-
bioRxiv - Immunology 2019Quote: ... rhIL-23 (20 ng mL−1, R&D Systems), rhIL-6 (20 ng mL−1 ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 20 ng/ml M-CSF (R&D Systems).
-
bioRxiv - Neuroscience 2020Quote: ... Recombinant Human NT3 (10 ng/ml, R&D Systems) and Doxycycline (5 μM ...
-
bioRxiv - Neuroscience 2020Quote: ... Recombinant Human NT3 (10 ng/ml, R&D Systems) and Doxycycline (5 μM ...
-
bioRxiv - Neuroscience 2020Quote: ... Recombinant Human BDNF (10 ng/ml, R&D Systems), Recombinant Human NT3 (10 ng/ml ...
-
bioRxiv - Cancer Biology 2019Quote: ... and 20 ng/mL FGF-2 (R&D Systems) in a humidified incubator with 5% CO2 ...
-
bioRxiv - Developmental Biology 2021Quote: ... FGF4 (25 ng/mL; R&D Systems, 5846-F4) and heparin (1 mg ml−1 ...
-
bioRxiv - Cancer Biology 2019Quote: ... and 20 ng/mL FGF-2 (R&D Systems) in a humidified incubator with 5% CO2.
-
bioRxiv - Immunology 2019Quote: ... and GM-CSF (50 ng/ml, R&D Systems) for seven days ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 500 ng/mL R-spondin (R&D Systems, 3474-RS-050 ...
-
bioRxiv - Biochemistry 2019Quote: ... 15 ng/mL Recombinant Mouse Matriptase (R&D Systems) and the substrate were incubated in assay buffer including 50 mM Tris-HCL (pH 8.5) ...
-
bioRxiv - Cell Biology 2019Quote: ... 10 ng/mL FGF (223-FB, R&D Systems). At 80% confluency ...
-
bioRxiv - Immunology 2019Quote: ... and 10 ng/mL IL-15 (R&D Systems). On day 2 of co-culture ...
-
bioRxiv - Bioengineering 2019Quote: ... and 80 ng mL−1 VEGF (R&D systems). After two more days in culture ...
-
bioRxiv - Molecular Biology 2020Quote: ... 20 ng/ml FGF2 (R&D Systems, #233-FB) and 20 ng/ml EGF (Peprotech ...
-
bioRxiv - Neuroscience 2020Quote: ... Recombinant Human BDNF (10 ng/ml, R&D Systems), Recombinant Human NT3 (10 ng/ml ...
-
bioRxiv - Cell Biology 2021Quote: ... and 30 ng/ml Activin A (R&D Systems), 5 ng/ml bFGF (R&D Systems ...
-
bioRxiv - Developmental Biology 2021Quote: ... and 30 ng/ml Activin A (R&D Systems), 5ng/ml bFGF (R&D Systems ...
-
bioRxiv - Neuroscience 2021Quote: ... 1 ng/mL recombinant rat CNTF (R&D Systems) [29] ...